PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Shanghai Fosun Pharmaceutical Group Co Ltd (2196.H...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCNE100001M79
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapHK$63.02B
EPSHK$0.87
PE Ratio9.32
PEG Ratio1.00
Revenue (TTM)HK$43.03B
Gross Profit (TTM)HK$20.70B
EBITDA (TTM)HK$4.52B
Year RangeHK$12.40 - HK$23.62
Target PriceHK$24.51

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 2196.HK

Shanghai Fosun Pharmaceutical Group Co Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Shanghai Fosun Pharmaceutical Group Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


50.00%100.00%150.00%200.00%250.00%OctoberNovemberDecember2024FebruaryMarch
40.78%
275.71%
2196.HK (Shanghai Fosun Pharmaceutical Group Co Ltd)
Benchmark (^GSPC)

S&P 500

Returns By Period

Shanghai Fosun Pharmaceutical Group Co Ltd had a return of -24.71% year-to-date (YTD) and -41.18% in the last 12 months. Over the past 10 years, Shanghai Fosun Pharmaceutical Group Co Ltd had an annualized return of -5.87%, while the S&P 500 had an annualized return of 10.89%, indicating that Shanghai Fosun Pharmaceutical Group Co Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-24.71%10.16%
1 month-11.23%3.47%
6 months-30.13%22.20%
1 year-41.18%30.45%
5 years (annualized)-13.61%13.16%
10 years (annualized)-5.87%10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-22.00%6.79%
2023-9.95%-0.33%-1.96%-4.21%-1.62%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
2196.HK
Shanghai Fosun Pharmaceutical Group Co Ltd
-1.36
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Shanghai Fosun Pharmaceutical Group Co Ltd Sharpe ratio is -1.36. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-1.36
2.77
2196.HK (Shanghai Fosun Pharmaceutical Group Co Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

Shanghai Fosun Pharmaceutical Group Co Ltd granted a 3.59% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.46 per share.


PeriodTTM20232022202120202019201820172016201520142013
DividendHK$0.46HK$0.46HK$0.66HK$0.52HK$0.43HK$0.36HK$0.46HK$0.40HK$0.38HK$0.36HK$0.34HK$0.26

Dividend yield

3.59%2.71%2.64%1.51%1.16%1.53%2.00%0.80%1.59%1.58%1.22%1.11%

Monthly Dividends

The table displays the monthly dividend distributions for Shanghai Fosun Pharmaceutical Group Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.46HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.66HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.52HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.43HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.36HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.46HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.40HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2016HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.38HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2015HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.36HK$0.00HK$0.00HK$0.00HK$0.00
2014HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.34HK$0.00HK$0.00HK$0.00HK$0.00
2013HK$0.26HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%3.6%
Shanghai Fosun Pharmaceutical Group Co Ltd has a dividend yield of 3.59%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%52.9%
Shanghai Fosun Pharmaceutical Group Co Ltd has a payout ratio of 52.87%, which is quite average when compared to the overall market. This suggests that Shanghai Fosun Pharmaceutical Group Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-82.65%
0
2196.HK (Shanghai Fosun Pharmaceutical Group Co Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Shanghai Fosun Pharmaceutical Group Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Shanghai Fosun Pharmaceutical Group Co Ltd was 82.86%, occurring on Feb 15, 2024. The portfolio has not yet recovered.

The current Shanghai Fosun Pharmaceutical Group Co Ltd drawdown is 82.65%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.86%Aug 5, 2021623Feb 15, 2024
-62.8%Mar 21, 2018489Mar 16, 2020278May 3, 2021767
-50.19%Jun 1, 2015162Jan 21, 2016338Jun 8, 2017500
-21.94%Jan 15, 201820Feb 9, 201825Mar 20, 201845
-19.74%Mar 12, 201426Apr 16, 2014247Apr 21, 2015273

Volatility

Volatility Chart

The current Shanghai Fosun Pharmaceutical Group Co Ltd volatility is 9.76%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%OctoberNovemberDecember2024FebruaryMarch
9.76%
2.80%
2196.HK (Shanghai Fosun Pharmaceutical Group Co Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Shanghai Fosun Pharmaceutical Group Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items